Amedeo Smart

Free Medical Literature Service

 

Amedeo

Obstructive Lung Diseases
  Free Subscription

Articles published in
J Investig Allergol Clin Immunol
    November 2024
  1. OJANGUREN I, Quirce S, Bobolea I, Perez de Llano L, et al
    Phenotyping Asthma Exacerbations: One Step Further in the Management of Severe Asthma.
    J Investig Allergol Clin Immunol. 2024 Nov 28:0. doi: 10.18176/jiaci.1043.
    >> Share

  2. MASCARO-HEREZA B, Loli-Ausejo D, Valero A, Arismendi E, et al
    Effectiveness of Biologics in Patients With Severe Asthma and Psychiatric Comorbidities.
    J Investig Allergol Clin Immunol. 2024 Nov 27:0. doi: 10.18176/jiaci.1034.
    >> Share

  3. RIAL MJ, Betancor D, Canas JA, Olaguibel JM, et al
    Stability of Asthma Phenotypes in the Spanish Cohort of the MEGA Project.
    J Investig Allergol Clin Immunol. 2024 Nov 25:0. doi: 10.18176/jiaci.1026.
    >> Share

  4. MIRALLES-LOPEZ JC, Andujar-Espinosa R, Bravo-Gutierrez FJ, Cabrejos-Perotti S, et al
    Tezepelumab in Patients With Severe Asthma: Response at 3 Months.
    J Investig Allergol Clin Immunol. 2024 Nov 25:0. doi: 10.18176/jiaci.1041.
    >> Share

  5. OZDEMIR O
    Occupational Asthma and Rhinoconjunctivitis due to Soybean in a Bakery Worker.
    J Investig Allergol Clin Immunol. 2024 Nov 13:0. doi: 10.18176/jiaci.1035.
    >> Share

  6. LOZANO-ESPINOSA M, Rodriguez-Otero N, Antolin-Amerigo D, Gordo Vidal F, et al
    Characteristics of Asthma Patients Admitted to the Intensive Care Unit of a Tertiary University Hospital in Madrid, Spain: A 5-Year Experience.
    J Investig Allergol Clin Immunol. 2024 Nov 12:0. doi: 10.18176/jiaci.1021.
    >> Share

    October 2024
  7. POLA-BIBIAN B, Dominguez-Ortega J, Vila-Nadal G, Entrala A, et al
    Asthma Exacerbations in a Tertiary Hospital: Clinical Features, Triggers, and Risk Factors for Hospitalization.
    J Investig Allergol Clin Immunol. 2024;27:238-245.
    >> Share

  8. PLAZA V, Eguiluz I, Garin N, Martinez Moragon E, et al
    EPI-SURVEY: Grade of Awareness Among Spanish Allergists, Hospital Pharmacists, and Pulmonologists of the Relevance of Bronchial Epithelium and Alarmins in the Pathogenesis and Management of Severe Asthma.
    J Investig Allergol Clin Immunol. 2024;34:336-338.
    >> Share

    July 2024
  9. VENEGAS GARRIDO C, Nair P, Davila I, Perez de Llano L, et al
    Role of Thymic Stromal Lymphopoietin in the Pathophysiology of Asthma and Clinical and Biological Effects of Blockade With Tezepelumab.
    J Investig Allergol Clin Immunol. 2024 Jul 26:0. doi: 10.18176/jiaci.1012.
    >> Share

    June 2024
  10. BETANCOR D, Otal M, Olaguibel JM, Rodrigo-Munoz JM, et al
    Global Lung Initiative as Diagnostic Criteria in Asthma-COPD Overlap Syndrome: Prevalence and Disease Characterization in a Real-Life Asthma Cohort.
    J Investig Allergol Clin Immunol. 2024;34:192-195.
    >> Share

  11. ZAKZUK J, Donado K, Mondol E, Marrugo V, et al
    IgE-Mediated Sensitization to Blo t 21 and Blo t 5 Is Associated With Asthma in the Tropics: A Case-Control Study.
    J Investig Allergol Clin Immunol. 2024;34:157-166.
    >> Share

    May 2024
  12. SOUSA-PINTO B, Fonseca JA, Bousquet J
    Contribution of MASK-air(R) as a mHealth tool for digitally-enabled person-centred care in rhinitis and asthma.
    J Investig Allergol Clin Immunol. 2024 May 14:0. doi: 10.18176/jiaci.0994.
    >> Share

  13. TOMAS-PEREZ M, Trisan Alonso A, Montoro-Ferrer A, Dominguez-Ortega J, et al
    Concomitant Efficacy of Dupilumab in Treating Eosinophilic Esophagitis and Type 2 Asthma.
    J Investig Allergol Clin Immunol. 2024 May 9:0. doi: 10.18176/jiaci.1011.
    >> Share

    April 2024
  14. DE LAS VECILLAS L, Quirce S
    The Multiple Trajectories of the Allergic March.
    J Investig Allergol Clin Immunol. 2024;34:75-84.
    >> Share

    February 2024
  15. SOUSA-PINTO B, Palamarchuk Y, Leemann L, Jankin S, et al
    From MASK-air and SILAM to CATALYSE (Climate Action To Advance HeaLthY Societies in Europe).
    J Investig Allergol Clin Immunol. 2024;34:12-19.
    >> Share

  16. PILIA MF, Espejo D, Soler D, Munoz X, et al
    Occupational Asthma due to alumina exposure.
    J Investig Allergol Clin Immunol. 2024 Feb 20:0. doi: 10.18176/jiaci.0974.
    >> Share

  17. PLAZA V, Eguiluz I, Garin N, Martinez Moragon E, et al
    EPI-SURVEY. Grade of awareness of Spanish allergist, hospital pharmacist, and pulmonologists on the relevance of bronchial epithelium and alarmins in the pathogenesis and management of severe asthma.
    J Investig Allergol Clin Immunol. 2024 Feb 14:0. doi: 10.18176/jiaci.0997.
    >> Share

  18. PLAZA V, Trigueros JA, Carretero JA, Ojanguren Arranz I, et al
    The use of triple therapy in asthma. The GEMA-FORUM V task force.
    J Investig Allergol Clin Immunol. 2024 Feb 9:0. doi: 10.18176/jiaci.0975.
    >> Share

    January 2024
  19. DOMINGUEZ-ORTEGA J, Colas C, Delgado Romero J, Habernau Mena A, et al
    Basal clinical characteristics and phenoendotypes of patients with severe asthma in Alergodata: The Spanish Allergy Society Registry.
    J Investig Allergol Clin Immunol. 2024 Jan 12:0. doi: 10.18176/jiaci.0989.
    >> Share

    December 2023
  20. BETANCOR D, Otal M, Olaguibel JM, Rodrigo-Munoz JM, et al
    Global Lung Initiative as diagnostic criteria in Asthma-COPD overlap syndrome. Prevalence and characterization of the syndrome in a real-life asthma cohort.
    J Investig Allergol Clin Immunol. 2023 Dec 22:0. doi: 10.18176/jiaci.0966.
    >> Share

  21. BETANCOR D, Valverde-Monge M, Barroso B, Gomez-Lopez A, et al
    Non-asthmatic eosinophilic bronquitis review. A systematic review of current treatment options.
    J Investig Allergol Clin Immunol. 2023 Dec 19:0. doi: 10.18176/jiaci.0984.
    >> Share

  22. PAOLETTI G, Casini M, Malvezzi L, Pirola F, et al
    Very Rapid Improvement in Extended Nitric Oxide Parameters Is Associated With Clinical and Functional Improvement in Patients With Chronic Rhinosinusitis With Nasal Polyps Treated With Dupilumab.
    J Investig Allergol Clin Immunol. 2023;33:457-463.
    >> Share

    October 2023
  23. NARVAEZ-FERNANDEZ E, Pose K, Caballero ML, Rodriguez-Perez R, et al
    Occupational asthma and food allergy due to soybean in a bakery worker.
    J Investig Allergol Clin Immunol. 2023 Oct 30:0. doi: 10.18176/jiaci.0958.
    >> Share

  24. ESPEJO D, Pilia F, Romero-Mesones C, Ojanguren I, et al
    Impact of obesity and lung function on the efficacy of biological treatment in patients with asthma.
    J Investig Allergol Clin Immunol. 2023 Oct 18:0. doi: 10.18176/jiaci.0941.
    >> Share

  25. MIRALLES-LOPEZ JC, Antolin-Amerigo D, Garcia-Moguel I, Dominguez-Ortega J, et al
    Positioning of Tezepelumab in severe asthma.
    J Investig Allergol Clin Immunol. 2023 Oct 9:0. doi: 10.18176/jiaci.0949.
    >> Share

    September 2023
  26. PEREZ DE LLANO L, Muniz Fernandez MC, Davila I
    Impact of the ERS/ATS 2021 guidelines for lung function interpretation on assessing the response to biologics in asthma.
    J Investig Allergol Clin Immunol. 2023 Sep 18:0. doi: 10.18176/jiaci.0943.
    >> Share

  27. BANTULA M, Arismendi E, Roca-Ferrer J, Picado C, et al
    IL-1R2 gene expression is downregulated in obesity-associated asthma.
    J Investig Allergol Clin Immunol. 2023 Sep 4:0. doi: 10.18176/jiaci.0928.
    >> Share

  28. JAFFUEL D, Serrano E, Leroyer C, Chartier A, et al
    SQ HDM sublingual immunotherapy tablet for the treatment of HDM allergic rhinitis and asthma improves subjective sleepiness and insomnia: an exploratory analysis of the real-life CARIOCA study.
    J Investig Allergol Clin Immunol. 2023 Sep 4:0. doi: 10.18176/jiaci.0934.
    >> Share

    June 2023
  29. GRANDA P, Villamanan E, Heinz S, Laorden D, et al
    Compassionate Use of Reslizumab in a Life-Threatening Asthma Exacerbation.
    J Investig Allergol Clin Immunol. 2023 Jun 21:0. doi: 10.18176/jiaci.0920.
    >> Share

  30. DE WIT J, Dalm VA, Totte JE, Kamphuis LS, et al
    Atopic Manifestations Are Underestimated Clinical Features in Various Primary Immunodeficiency Disease Phenotypes.
    J Investig Allergol Clin Immunol. 2023;33:200-208.
    >> Share

  31. ARISMENDI E, Cisneros C, Blanco-Aparicio M, Martinez-Moragon E, et al
    REDES study: Mepolizumab is effective in patients with severe asthma and comorbid nasal polyps.
    J Investig Allergol Clin Immunol. 2023 Jun 8:0. doi: 10.18176/jiaci.0905.
    >> Share

  32. KIM YH, Park MR, Kim SY, Kim MY, et al
    Respiratory microbiome profiles are associated with distinct inflammatory phenotype and lung function in children with asthma.
    J Investig Allergol Clin Immunol. 2023 Jun 1:0. doi: 10.18176/jiaci.0918.
    >> Share

  33. POSE K, Laorden D, Hernandez N, Villamanan E, et al
    Efficacy of Dupilumab for Severe Atopic Dermatitis Co-occurring With Asthma in a Real-World Setting.
    J Investig Allergol Clin Immunol. 2023;33:217-219.
    >> Share

  34. QUIRCE S, Trigueros JA, Ausin P, Munoz Cano R, et al
    Role of Different Health Care Professionals in the Management of Asthma Patients: The GEMA-FORUM IV Task Force.
    J Investig Allergol Clin Immunol. 2023;33:214-217.
    >> Share

    April 2023
  35. HAROUN-DIAZ E, Vazquez de la Torre M, Somoza ML, Blanca-Lopez N, et al
    Occupational Rhinitis Due to Coati Allergy and Cross-reactivity With Dog Serum Albumin.
    J Investig Allergol Clin Immunol. 2023;33:147-148.
    >> Share

    March 2023
  36. MORA T, Sanchez-Collado I, Mullol J, Ribo P, et al
    Prevalence of asthma in Catalonia (Spain): a retrospective, large-scale population-based study.
    J Investig Allergol Clin Immunol. 2023 Mar 24:0. doi: 10.18176/jiaci.0903.
    >> Share

    February 2023
  37. LOLI-AUSEJO D, Perdomo G, Mascaro B, Martinez-Olondris P, et al
    Mepolizumab treatment for severe eosinophilic asthma: a 5-years real-life experience.
    J Investig Allergol Clin Immunol. 2023 Feb 23:0. doi: 10.18176/jiaci.0898.
    >> Share

  38. ZAKZUK J, Donado K, Mondol E, Marrugo V, et al
    IgE sensitization to Blo t 21 and Blo t 5 is associated with asthma in the tropics: a case-control study.
    J Investig Allergol Clin Immunol. 2023 Feb 21:0. doi: 10.18176/jiaci.0892.
    >> Share

  39. MARQUES-MEJIAS MA, Tomas-Perez M, Hernandez-Martin I, Loli-Ausejo D, et al
    Recurrent Bronchospasm in Children Treated in the Emergency Department.
    J Investig Allergol Clin Immunol. 2023;33:49-51.
    >> Share

    January 2023
  40. MONTORO J, Antolin-Amerigo D, Izquierdo-Dominguez A, Zapata JJ, et al
    The impact of inhalers for asthma on the global climate: a systematic review of carbon footprint and clinical outcomes in Spain.
    J Investig Allergol Clin Immunol. 2023 Jan 17:0. doi: 10.18176/jiaci.0887.
    >> Share

  41. YEN-JUNG L, Hsin-Kuo K, Sheng-Wei P, Jia-Yih F, et al
    Airway reactance predicts static lung hyperinflation in severe asthma.
    J Investig Allergol Clin Immunol. 2023 Jan 16:0. doi: 10.18176/jiaci.0888.
    >> Share

    December 2022
  42. PEREZ DE LLANO L, Martinez Moragon E, Entrenas LM, Martinez Rivera C, et al
    Validation of the Asthma Impairment and Risk Questionnaire (AIRQ) in Spain: a useful tool to assess asthma control in adolescent and adult patients.
    J Investig Allergol Clin Immunol. 2022 Dec 15:0. doi: 10.18176/jiaci.0881.
    >> Share

  43. GIL-MARTINEZ M, Rodrigo-Munoz JM, Sastre B, Canas JA, et al
    Serum microRNAs Catalog Asthma Patients by Phenotype.
    J Investig Allergol Clin Immunol. 2022;32:471-478.
    >> Share

    November 2022
  44. HERRERA-LUIS E, Forno E, Celedon JC, Pino-Yanes M, et al
    Asthma exacerbations: the genes behind the scenes.
    J Investig Allergol Clin Immunol. 2022 Nov 24:0. doi: 10.18176/jiaci.0878.
    >> Share

  45. CASTILLA-MARTINEZ M, Andujar-Espinosa R, Flores-Martin I, Reyes Cotes MH, et al
    Early effectivity of dupilumab in patients with t2 severe asthma: a prospective real-life study.
    J Investig Allergol Clin Immunol. 2022 Nov 22:0. doi: 10.18176/jiaci.0872.
    >> Share

  46. DOMINGO C, Sicras-Mainar A, Sicras-Navarro A, Sogo A, et al
    Prevalence, T2-biomarkers and cost of severe asthma in the era of biologics: The BRAVO-1 study.
    J Investig Allergol Clin Immunol. 2022 Nov 22:0. doi: 10.18176/jiaci.0871.
    >> Share

  47. MIGUERES N, Vandenplas O, Walusiak-Skorupa J, Wiszniewska M, et al
    Sputum Inflammatory Patterns are Associated with Distinct Clinical Characteristics in Subjects with Occupational Asthma Independently from the Causal Agent.
    J Investig Allergol Clin Immunol. 2022 Nov 8:0. doi: 10.18176/jiaci.0868.
    >> Share

    October 2022
  48. BETANCOR D, Olaguibel JM, Rodrigo-Munoz JM, Alvarez Puebla MJ, et al
    Lung function abnormalities and their correlation with clinical characteristics and inflammatory markers in adult asthma.
    J Investig Allergol Clin Immunol. 2022 Oct 17:0. doi: 10.18176/jiaci.0866.
    >> Share

  49. ESTEBAN-GORGOJO I, Gorgojo MP, Sastre J, Garcia-Rio F, et al
    The influence of BMI in asthma. Which traits are due to obesity and which to asthma and obesity phenotype?
    J Investig Allergol Clin Immunol. 2022 Oct 6:0. doi: 10.18176/jiaci.0865.
    >> Share

    September 2022
  50. MOYA B, Huang C, Kjarsgaard M, Martin-Arriscado C, et al
    Exhaled breath temperature is not helpful to identify cellular bronchitis in severe asthma.
    J Investig Allergol Clin Immunol. 2022 Sep 29:0. doi: 10.18176/jiaci.0862.
    >> Share

  51. BANTULA M, Tubita V, Roca-Ferrer J, Mullol J, et al
    Weight loss and vitamin D improve hyporesponsiveness to corticosteroids in obese asthma.
    J Investig Allergol Clin Immunol. 2022 Sep 8:0. doi: 10.18176/jiaci.0861.
    >> Share

  52. MATUCCI A, Micheletto C, Vultaggio A
    Severe asthma and biologics: managing complex patients.
    J Investig Allergol Clin Immunol. 2022 Sep 1:0. doi: 10.18176/jiaci.0856.
    >> Share

    August 2022
  53. PEREZ DE LLANO L, Cisneros C, Dominguez-Ortega J, Martinez-Moragon E, et al
    Response to monoclonal antibodies in asthma: definitions, potential reasons for failure and therapeutic options for suboptimal response.
    J Investig Allergol Clin Immunol. 2022 Aug 30:0. doi: 10.18176/jiaci.0857.
    >> Share

  54. MILGER K, Skowasch D, Hamelmann E, Mummler C, et al
    Bronchodilator reversibility in the GAN severe asthma cohort.
    J Investig Allergol Clin Immunol. 2022 Aug 24:0. doi: 10.18176/jiaci.0850.
    >> Share

  55. MELERO MORENO C, Almonacid Sanchez C, Banas Conejero D, Quirce S, et al
    Understanding severe asthma through small and Big Data in Spanish hospitals - PAGE Study.
    J Investig Allergol Clin Immunol. 2022 Aug 24:0. doi: 10.18176/jiaci.0848.
    >> Share

    June 2022
  56. OTANI T, Iwamoto H, Horimasu Y, Yamaguchi K, et al
    Effect of dupilumab in a patient with severe asthma complicated with recurrent anaphylaxis: a case report.
    J Investig Allergol Clin Immunol. 2022 Jun 27:0. doi: 10.18176/jiaci.0840.
    >> Share

  57. ALMONACID SANCHEZ C, Blanco-Aparicio M, Dominguez-Ortega J, Giner Donaire J, et al
    Validation of the algorithm for the monitoring and control of asthma through telemedicine. The Consensus COMETA Project.
    J Investig Allergol Clin Immunol. 2022 Jun 27:0. doi: 10.18176/jiaci.0841.
    >> Share

  58. PEREZ DE LLANO LA, Cosio BG, Lobato Astiarraga I, Soto Campos G, et al
    First line versus second line use of reslizumab in severe uncontrolled asthma.
    J Investig Allergol Clin Immunol. 2022 Jun 27:0. doi: 10.18176/jiaci.0839.
    >> Share

  59. POSE K, Laorden D, Hernandez N, Villamanan E, et al
    Concomitant Efficacy of Dupilumab for severe atopic dermatitis and comorbid asthma in real-life conditions.
    J Investig Allergol Clin Immunol. 2022 Jun 20:0. doi: 10.18176/jiaci.0837.
    >> Share

  60. OLAGUIBEL JM, Sastre J, Rodriguez JM, Del Pozo V, et al
    Eosinophilia Induced by Blocking the IL-4/IL-13 Pathway: Potential Mechanisms and Clinical Outcomes.
    J Investig Allergol Clin Immunol. 2022;32:165-180.
    >> Share

  61. QUIRCE S, Trigueros JA, Ausin P, Munoz Cano R, et al
    Role of the different healthcare professionals in the management of asthma patients. The GEMA-FORUM IV task force.
    J Investig Allergol Clin Immunol. 2022 Jun 8:0. doi: 10.18176/jiaci.0833.
    >> Share

    May 2022
  62. GONZALEZ O, Picado C, Alobid I, Ramirez J, et al
    Eosinophilic sialodochitis: a rare comorbidity of severe asthma.
    J Investig Allergol Clin Immunol. 2022 May 2:0. doi: 10.18176/jiaci.0817.
    >> Share

  63. DOMINGUEZ-ORTEGA J, Luna-Porta JA, Olaguibel JM, Barranco E, et al
    Exacerbations among patients with asthma are largely dependent on the presence of multimorbidity.
    J Investig Allergol Clin Immunol. 2022 May 2:0. doi: 10.18176/jiaci.0816.
    >> Share

    April 2022
  64. IZQUIERDO E, Rodriguez-Coira J, Delgado-Dolset MI, Gomez-Casado C, et al
    Epithelial Barrier: Protector and Trigger of Allergic Disorders.
    J Investig Allergol Clin Immunol. 2022;32:81-96.
    >> Share

  65. URIARTE SA, Gronlund H, Wintersand A, Bronge J, et al
    Clinical and Immunologic Changes due to Subcutaneous Immunotherapy With Cat and Dog Extracts Using an Ultrarush Up-Dosing Phase: A Real-Life Study.
    J Investig Allergol Clin Immunol. 2022;32:133-140.
    >> Share

  66. BARROSO B, Valverde-Monge M, Alobid I, Olaguibel JM, et al
    Smell improvement by anti-IgE and anti-IL 5 biologics in patients with CRSwNP and severe asthma. A real life study.
    J Investig Allergol Clin Immunol. 2022 Apr 12:0. doi: 10.18176/jiaci.0812.
    >> Share

    March 2022
  67. SALOMONSSON M, Cardenas EI, Dahlin JS, Kalm-Stephens P, et al
    The proportion of FceRI+ blood monocytes increases with the degree of IgE sensitization in asthma.
    J Investig Allergol Clin Immunol. 2022 Mar 2:0. doi: 10.18176/jiaci.0797.
    >> Share

    February 2022
  68. MIRALLES LOPEZ JC, Andujar-Espinosa R, Bravo-Gutierrez FJ, Castilla-Martinez M, et al
    Effectiveness of benralizumab in severe eosinophilic asthma under routine clinical practice.
    J Investig Allergol Clin Immunol. 2022 Feb 11:0. doi: 10.18176/jiaci.0793.
    >> Share

    January 2022
  69. DELGADO ROMERO J, Blanco-Aparicio M, Cisneros Serrano C, Diaz-Perez D, et al
    Biological therapy at-home administration support for patients with severe asthma BioCart(c).
    J Investig Allergol Clin Immunol. 2022 Jan 24:0. doi: 10.18176/jiaci.0786.
    >> Share

  70. VALVERDE-MOLINA J, Fernandez-Nieto M, Torres-Borrego J, Lozano Blasco J, et al
    Transition of adolescents with severe asthma from pediatric to adult care in Spain: the STAR consensus.
    J Investig Allergol Clin Immunol. 2022 Jan 12:0. doi: 10.18176/jiaci.0780.
    >> Share

    December 2021
  71. LEIRIA-PINTO P, Carreiro-Martins P, Peralta I, Marques J, et al
    Factors Associated With Asthma Control in 121 Preschool Children.
    J Investig Allergol Clin Immunol. 2021;31:471-480.
    >> Share

  72. DELGADO-ROMERO J, Pereyra-Rodriguez JJ
    Asthma mortality in Spain from 1980 to 2019. Trends and perspectives in new treatment era.
    J Investig Allergol Clin Immunol. 2021 Dec 13:0. doi: 10.18176/jiaci.0771.
    >> Share

    November 2021
  73. ANTONICELLI L, Tontini C, Garritani MS, Piga MA, et al
    Efficacy of mepolizumab in patients with concomitant severe eosinophilic asthma and severe chronic urticaria: an example of personalized medicine?
    J Investig Allergol Clin Immunol. 2021 Nov 29:0. doi: 10.18176/jiaci.0770.
    >> Share

  74. VALERO A, Molina J, Nuevo J, Simon S, et al
    Economic consequences of the overuse of short-acting beta-adrenergic agonists (SABA) in the treatment of asthma in Spain.
    J Investig Allergol Clin Immunol. 2021 Nov 26:0. doi: 10.18176/jiaci.0767.
    >> Share

  75. KALM-STEPHENS P, Nordvall L, Janson C, Malinovschi A, et al
    Sex differences in baseline risk factors for the incidence of asthma between early adolescence and young adulthood.
    J Investig Allergol Clin Immunol. 2021 Nov 18:0. doi: 10.18176/jiaci.0763.
    >> Share

  76. IZQUIERDO JL, Almonacid C, Campos C, Morena D, et al
    Systemic Corticosteroids in Patients with Bronchial Asthma: A Real-Life Study.
    J Investig Allergol Clin Immunol. 2021 Nov 11:0. doi: 10.18176/jiaci.0765.
    >> Share

    October 2021
  77. PACHOLCZAK-MADEJ R, Kuszmiersz P, Iwaniec T, Zareba L, et al
    Endothelial Dysfunction and Pentraxin-3 in Clinically Stable Adult Asthma Patients.
    J Investig Allergol Clin Immunol. 2021;31:417-425.
    >> Share

  78. VILLALOBOS-VIOLAN V, Betancor D, Mahillo-Fernandez I, Sastre J, et al
    Nonasthmatic Eosinophilic Bronchitis and Asthma Development: analysis of biomarkers.
    J Investig Allergol Clin Immunol. 2021 Oct 15:0. doi: 10.18176/jiaci.0738.
    >> Share

  79. LEAL M, Paciencia I, Farraia M, Cavaleiro Rufo J, et al
    Airborne Food Allergen and Aeroallergen Levels in Health Care Settings: An Unaccounted for but Potentially Relevant Source of Exposure?
    J Investig Allergol Clin Immunol. 2021;31:426-432.
    >> Share

    September 2021
  80. DAVILA I, Campo P, Cimbollek S, Almonacid Sanchez C, et al
    Cluster sub-analysis of patients with severe asthma who responded to omalizumab.
    J Investig Allergol Clin Immunol. 2021 Sep 28:0. doi: 10.18176/jiaci.0731.
    >> Share

    July 2021
  81. ALMONACID SANCHEZ C, Melero Moreno C, Quirce Gancedo S, Sanchez-Herrero MG, et al
    PAGE Study: Summary of a Study Protocol to Estimate the Prevalence of Severe Asthma in Spain Using Big Data Methods.
    J Investig Allergol Clin Immunol. 2021;31:308-315.
    >> Share

    June 2021
  82. PEREZ DE LLANO L, Blanco Cid N, Ortiz Piquer M, Dacal Rivas D, et al
    Compassionate Use of a Single Dose of Benralizumab in a Near-Fatal Asthma Exacerbation.
    J Investig Allergol Clin Immunol. 2021;31:268-270.
    >> Share

  83. JACOME C, Pereira R, Almeida R, Amaral R, et al
    Validation of App and Phone Versions of the Control of Allergic Rhinitis and Asthma Test (CARAT).
    J Investig Allergol Clin Immunol. 2021;31:270-273.
    >> Share

  84. BENZECRY V, Pravettoni V, Segatto G, Marzano AV, et al
    Type 2 Inflammation: Atopic Dermatitis, Asthma, and Hypereosinophilia Successfully Treated With Dupilumab.
    J Investig Allergol Clin Immunol. 2021;31:261-263.
    >> Share

    April 2021
  85. BARRANCO P, Palao P, Ruiz I, Dominguez-Ortega J, et al
    Relationship Between IgE-Mediated Sensitization to Staphylococcus aureus Enterotoxin B, Asthma Severity, and Atopy.
    J Investig Allergol Clin Immunol. 2021;31:170-173.
    >> Share

  86. DELGADO ROMERO J, Miralles Lopez JC, Alvarez Puebla M, Fernandez Ibanez E, et al
    Severe Asthma Units Accredited by the Spanish Society of Allergology and Clinical Immunology (SEAIC): Experience and Future.
    J Investig Allergol Clin Immunol. 2021;31:182-184.
    >> Share

  87. DELGADO J, Martinez-Moragon E, Fernandez-Sanchez T
    Factors Affecting the Success of Step-up Therapy in Patients With Moderate-Severe Asthma: A Real-Life Study.
    J Investig Allergol Clin Immunol. 2021;31:145-150.
    >> Share

  88. TEJEDOR-ALONSO MA, Farias-Aquino E, Perez-Fernandez E, Moro-Moro M, et al
    Association Between Severity of Anaphylaxis and Co-occurrence of Respiratory Diseases: A Systematic Review and Meta-analysis of Observational Studies.
    J Investig Allergol Clin Immunol. 2021;31:132-144.
    >> Share

    February 2021
  89. DELGADO J, Davila IJ, Dominguez-Ortega J
    Clinical Recommendations for the Management of Biological Treatments in Severe Asthma Patients: A Consensus Statement.
    J Investig Allergol Clin Immunol. 2021;31:36-43.
    >> Share

  90. MIRALLES LOPEZ JC, Escudero Pastor AI, Carbonell Martinez A, Navarro Garrido C, et al
    Benralizumab in Real Life.
    J Investig Allergol Clin Immunol. 2021;31:87-88.
    >> Share

  91. PLAZA V, Giner J, Curto E, Alonso-Ortiz MB, et al
    Assessing Adherence by Combining the Test of Adherence to Inhalers With Pharmacy Refill Records.
    J Investig Allergol Clin Immunol. 2021;31:58-64.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016